Leidos (NYSE:LDOS) Price Target Raised to $210.00

Leidos (NYSE:LDOS) had its price target upped by Barclays from $165.00 to $210.00 in a research note released on Monday, Benzinga reports. The firm currently has an overweight rating on the aerospace company’s stock.

LDOS has been the topic of a number of other reports. JPMorgan Chase & Co. increased their price target on shares of Leidos from $175.00 to $185.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. The Goldman Sachs Group increased their target price on shares of Leidos from $205.00 to $228.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Wells Fargo & Company boosted their price target on shares of Leidos from $183.00 to $230.00 and gave the company an “overweight” rating in a research report on Wednesday, October 30th. Bank of America increased their price objective on Leidos from $160.00 to $165.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Finally, Citigroup boosted their target price on Leidos from $194.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $191.23.

Leidos Price Performance

NYSE LDOS opened at $194.20 on Monday. The company has a market cap of $25.91 billion, a PE ratio of 22.12, a price-to-earnings-growth ratio of 1.48 and a beta of 0.68. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87. The firm’s 50-day simple moving average is $165.11 and its two-hundred day simple moving average is $152.75. Leidos has a 52 week low of $102.21 and a 52 week high of $198.99.

Leidos (NYSE:LDOS) last released its quarterly earnings data on Tuesday, October 29th. The aerospace company reported $2.93 EPS for the quarter, topping the consensus estimate of $1.96 by $0.97. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The company had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $4.06 billion. During the same period last year, the firm earned $2.03 EPS. Leidos’s revenue for the quarter was up 6.9% on a year-over-year basis. Research analysts predict that Leidos will post 10.07 earnings per share for the current year.

Leidos Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Monday, December 16th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date of this dividend is Friday, December 13th. This is a boost from Leidos’s previous quarterly dividend of $0.38. Leidos’s dividend payout ratio (DPR) is presently 17.31%.

Insider Buying and Selling at Leidos

In other news, Director Robert C. Kovarik, Jr. sold 1,047 shares of Leidos stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $184.94, for a total value of $193,632.18. Following the transaction, the director now owns 6,408 shares in the company, valued at approximately $1,185,095.52. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Robert C. Kovarik, Jr. sold 1,047 shares of the firm’s stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $184.94, for a total value of $193,632.18. Following the transaction, the director now owns 6,408 shares in the company, valued at approximately $1,185,095.52. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gary Stephen May sold 1,000 shares of the company’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $144.02, for a total transaction of $144,020.00. Following the sale, the director now owns 11,264 shares of the company’s stock, valued at $1,622,241.28. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.96% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Empirical Finance LLC increased its stake in shares of Leidos by 2.3% during the third quarter. Empirical Finance LLC now owns 4,492 shares of the aerospace company’s stock valued at $732,000 after buying an additional 103 shares during the period. CIBC Asset Management Inc increased its position in Leidos by 10.7% during the 3rd quarter. CIBC Asset Management Inc now owns 20,195 shares of the aerospace company’s stock valued at $3,292,000 after purchasing an additional 1,957 shares during the period. OneDigital Investment Advisors LLC raised its holdings in Leidos by 82.1% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 5,359 shares of the aerospace company’s stock worth $874,000 after purchasing an additional 2,416 shares in the last quarter. Metis Global Partners LLC lifted its position in shares of Leidos by 51.5% in the 3rd quarter. Metis Global Partners LLC now owns 6,358 shares of the aerospace company’s stock worth $1,036,000 after purchasing an additional 2,161 shares during the period. Finally, KBC Group NV boosted its stake in shares of Leidos by 23.7% during the 3rd quarter. KBC Group NV now owns 13,869 shares of the aerospace company’s stock valued at $2,261,000 after purchasing an additional 2,658 shares in the last quarter. Hedge funds and other institutional investors own 76.12% of the company’s stock.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.